N-PX 1 v024642_npx.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number    811-09123

AMIDEX Funds, Inc.
(Exact name of registrant as specified in charter)
 

2621 Van Buren Avenue
 
Norristown, Pa 19403
(Address of principal executive offices)
 
(Zip code)
 
   
Matrix Group, Inc., 630-A Fitzwatertown Road
 
Willow Grove, PA 19090
(Name and address of agent for service)
   
  

Registrant’s telephone number, including area code: 610 666-1330 

Date of fiscal year end:   05/31/2006

Date of reporting period:   06/30/2005

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1 -4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
   
SEC 2451 (4-03) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

  
 


                     
Fund #
Company Name
Symbol
CUSIP
Date
Matter #
Matter
Proposed By
Vote casted
Vote
Management Vote
           
 
issuer
Yes
For
For
           
 
holder
No
Against
Against
           
 
 
 
Abstain
Abstain
AMIDEX Cancer Innovations & Healthcare Fund
Verint
VRNT
92343X100
07/27/04
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Verint
VRNT
92343X100
07/27/04
2
Approve equity incentive plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Verint
VRNT
92343X100
07/27/04
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Ectel
ECTX
M29925100
07/29/04
1
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Ectel
ECTX
M29925100
07/29/04
2
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Ectel
ECTX
M29925100
07/29/04
3
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
M. A. Industries
MAIN
 
07/31/04
1
Allotment of options to Directors
issuer
Yes
For
For
AMIDEX35 Israel
Delek Group
DELKG
 
08/04/04
5
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Delek Group
DELKG
 
08/04/04
6
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Delek Group
DELKG
 
08/04/04
7
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
Delek Group
DELKG
 
08/04/04
8
Approve Chairman annual bonus
issuer
Yes
Against
For
AMIDEX35 Israel
Delek Group
DELKG
 
08/04/04
9
Approve remuneration and expenses of Directors
issuer
Yes
Against
For
AMIDEX35 Israel
Delek Group
DELKG
 
08/04/04
10
Approve D&O insurance for Directors
issuer
Yes
For
For
AMIDEX35 Israel
The Israel Corp
ILCO
 
08/04/04
1
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Taro Pharmaceuticals
TARO
M8737E108
08/05/04
1
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Taro Pharmaceuticals
TARO
M8737E108
08/05/04
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Taro Pharmaceuticals
TARO
M8737E108
08/05/04
3
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Taro Pharmaceuticals
TARO
M8737E108
08/05/04
4
Allotment of options to Directors
issuer
Yes
For
For
AMIDEX35 Israel
Discount Investment
DISI
 
08/10/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Discount Investment
DISI
 
08/10/04
2
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Discount Investment
DISI
 
08/10/04
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Tularik
TLRK
899165104
08/12/04
1
Approve the merger of Tularik and Arrow Aqcquisition
issuer
Yes
For
For
AMIDEX35 Israel
M. A. Industries
MAIN
 
08/30/04
1
Allotment of options to Directors
issuer
Yes
Against
For
AMIDEX35 Israel
M. A. Industries
MAIN
 
08/30/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
M. A. Industries
MAIN
 
08/30/04
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
M. A. Industries
MAIN
 
08/30/04
3
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
M. A. Industries
MAIN
 
08/30/04
4
Approve D&O insurance for Directors
issuer
Yes
For
For
AMIDEX35 Israel
M. A. Industries
MAIN
 
08/30/04
5
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
The Israel Corp
ILCO
 
09/08/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
The Israel Corp
ILCO
 
09/08/04
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
The Israel Corp
ILCO
 
09/08/04
3
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
The Israel Corp
ILCO
 
09/08/04
4
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Ectel
ECTX
M29925101
09/13/04
1
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX35 Israel
Ectel
ECTX
M29925101
09/13/04
2
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Ectel
ECTX
M29925101
09/13/04
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Ectel
ECTX
M29925101
09/13/04
4
Increase the number of ordinary shares of the compant underlyingoption plan
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
2
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
3
Approve the term of employment of Chairman
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
4
Approve the term of employment of Mr. Dankner, a controling shareholder
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
5
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
6
Receive the report as to the fees of the auditors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
7
Approve D&O insurance for Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
8
Amend article of association regarding quorum at Board meetings
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
9
Amend article of association regarding the authority to grant rights of signature
issuer
Yes
For
For
AMIDEX35 Israel
Bank Hapoalim
POLI
 
09/13/04
10
Approve the grant of indemnityundertaking to a Director
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
09/14/04
14
Approve D&O insurance for Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
09/14/04
15
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Clal Insurance
SLIS
 
09/21/04
1
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
United Mizrahi Bank
MZRH
 
09/22/04
1
Approve the merger of United Mizrahi Bank and United Mizrahi Investment Co.
issuer
Yes
For
For
AMIDEX35 Israel
United Mizrahi Bank
MZRH
 
09/22/04
1
Approve the merger of United Mizrahi Bank and United Mizrahi Investment Co.
issuer
Yes
For
For
AMIDEX35 Israel
Clal Industries
CII
 
09/26/04
1
Approve sharing agreement between various companies in the group
issuer
Yes
For
For
AMIDEX35 Israel
IDB Development
IDBD
 
09/26/04
1
Approve sharing agreement between various companies in the group
issuer
Yes
For
For
AMIDEX35 Israel
Clal Industries
CLIS
 
10/06/04
1
Approve the entry by the company
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
10/12/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
10/12/04
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
10/12/04
3
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
10/12/04
4
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
10/12/04
5
Approve D&O insurance for Directors
issuer
Yes
For
For
AMIDEX35 Israel
Partner Communiocations
PTNR
 
10/20/04
1
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Partner Communiocations
PTNR
 
10/20/04
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Partner Communiocations
PTNR
 
10/20/04
3
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Partner Communiocations
PTNR
 
10/20/04
4
Approve the provision of indemnification letters to Directors
issuer
Yes
For
For
AMIDEX35 Israel
Partner Communiocations
PTNR
 
10/20/04
5
Approve the provision of indemnification letters to external Directors
issuer
Yes
For
For
AMIDEX35 Israel
Partner Communiocations
PTNR
 
10/20/04
6
Approve the provision of indemnification letters to would be Directors
issuer
Yes
For
For
AMIDEX35 Israel
Partner Communiocations
PTNR
 
10/20/04
7
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
M-Systems Flash
FLSH
 
11/04/04
1
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
M-Systems Flash
FLSH
 
11/04/04
2
Approve to amend Directors stock puchase plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Myriad Genetics
MYGN
62855J-104
11/11/04
1
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Myriad Genetics
MYGN
62855J-104
11/11/04
2
Approve to amend Directors stock puchase plan
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Myriad Genetics
MYGN
62855J-104
11/11/04
3
Approve to amend employee stock puchase plan
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Myriad Genetics
MYGN
62855J-104
11/11/04
4
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
IDB Development
IDBD
 
11/15/04
1
Appoint an External Director
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
 
11/19/04
1
Approve issuance of shares for merger w/ Atrix
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Immunomedics
IMMU
452907-108
12/01/04
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
12/07/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
12/07/04
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
12/07/04
3
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
12/07/04
4
Approve remuneration and expenses of Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
12/07/04
5
Amend provisions of the Article of Association
issuer
Yes
Against
For
AMIDEX35 Israel
Bezeq
BEZQ
 
12/07/04
6
Approve Bonuses for Employees
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Enzon Pharmaceuticals
ENZN
293904-108
12/07/04
1
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Enzon Pharmaceuticals
ENZN
293904-108
12/07/04
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Israel Corporation
ILCO
 
12/09/04
1
Approve Transaction in Accordance with a Subsidiary of the Company
issuer
Yes
For
For
AMIDEX35 Israel
Israel Chemicals
CHIM
 
12/13/04
1
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX35 Israel
Osem Investments
OSEM
 
12/14/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Osem Investments
OSEM
 
12/14/04
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Osem Investments
OSEM
 
12/14/04
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Osem Investments
OSEM
 
12/14/04
4
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Israel Discount Bank
DSCT
 
12/23/04
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Israel Discount Bank
DSCT
 
12/23/04
2
Approve Dividend
issuer
Yes
For
For
AMIDEX35 Israel
Israel Discount Bank
DSCT
 
12/23/04
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Israel Discount Bank
DSCT
 
12/23/04
4
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Elbit Systems
ESLT
 
12/27/04
1
Approve Agreements Regarding Purchase of Shares
issuer
Yes
For
For
AMIDEX35 Israel
Elbit Systems
ESLT
 
12/27/04
2
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
01/16/05
1
Approve to Enter in to an Agreement Between Two Parties
issuer
Yes
For
For
AMIDEX35 Israel
Discount Investment
DISI
 
01/18/05
1
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
01/20/05
1
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
01/20/05
2
Approve to Distribute a Dividend
issuer
Yes
For
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
01/20/05
3
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
02/01/05
1
Approve to Distribute a Dividend
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
02/01/05
2
Approve the Purchase of a New D&O Insurance Policy
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
02/01/05
3
Appoint an External Director
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
02/11/05
1
Approve Limited Liability Company Agreement
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
02/11/05
2
Approve Entry of Joint Company into an Operating Agreement
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
02/11/05
3
Approve the Agreement by the Joint Company
issuer
Yes
For
For
AMIDEX35 Israel
Africa-Israel Investments
AFIL
 
02/11/05
4
Approve Entry of Joint Company into an Operating Agreement
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
02/11/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
02/11/05
2
Approve Bonus to Chairman of the Board for 2004
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Varian Medical Systems
VAR
92220P-105
02/17/05
1
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Varian Medical Systems
VAR
92220P-105
02/17/05
2
Approve Varian Medical Systems, Inc. 2005 Omnibus Stock Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Varian Medical Systems
VAR
92220P-105
02/17/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Agis Industries
AGIS
 
02/28/05
1
Approve Merger Agreement Between the Company and Perrigo
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Novartis AG
NVS
66987V109
03/01/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Novartis AG
NVS
66987V109
03/01/05
2
Approve Activities of the Board of Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Novartis AG
NVS
66987V109
03/01/05
3
Appropriation of Available Earnings of Novartis AG
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Novartis AG
NVS
66987V109
03/01/05
4
Reduction of Share Capital
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Novartis AG
NVS
66987V109
03/01/05
5
Further Share Repurchase Program
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Novartis AG
NVS
66987V109
03/01/05
6
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Novartis AG
NVS
66987V109
03/01/05
7
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-108
03/09/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-109
03/09/05
2
Confirm Dividends
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-110
03/09/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-111
03/09/05
4
Authorize Directors to Agree the Remuneration of the Auditor
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-112
03/09/05
5
Approve the Directors' Remuneration Report for the Year Ended
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-113
03/09/05
6
Approve Astrazeneca Performance Share Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-114
03/09/05
7
Authorize Limited EU Political Donations
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-115
03/09/05
8
Authorize Directors to Allot Unissued Shares
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-116
03/09/05
9
Authorize Directors to Disapply Pre-Emption Rights
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Astrazeneca
AZN
046353-117
03/09/05
10
To Authorize the Company to Purchase its Own Shares
issuer
Yes
For
For
AMIDEX35 Israel
Israel Discount Bank
DSCT
 
03/21/05
1
Approve that the Bank Should Join as a party to an Agreement
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
03/22/05
1
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
03/22/05
2
Approve to Grant Indemnity Undertaking to D&O
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
03/22/05
3
Approve to Pay Employment Severance Payments to the Outgoing Chairman
issuer
Yes
Against
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
03/30/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
03/30/05
2
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
03/30/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
03/30/05
4
Approve the Distribution of Dividend for the Year 2004
issuer
Yes
For
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
03/30/05
5
Approve Payment of a Bonus
issuer
Yes
Against
For
AMIDEX35 Israel
Migdal Insurance
MGDL
 
03/30/05
6
Approve Payment of a Bonus
issuer
Yes
Against
For
AMIDEX35 Israel
ECI Telecom
ECIL
 
04/11/05
1
Approval of Compensation of Member of Board of Directors
issuer
Yes
For
For
AMIDEX35 Israel
ECI Telecom
ECIL
 
04/11/05
2
Approval of the Sale to ABN Amro Bank N.V. of Long-term Notes
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Genentech Inc.
DNA
368710-406
04/14/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Genentech Inc.
DNA
368710-406
04/14/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
1
Elect Directors
issuer
Yes
Abstain
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
3
Separating the Roles of Chairman and Chief Executive Officer
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
4
Importation of Prescription Drugs
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
5
Report on the Impact of Limiting Product Supply to Canada
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
6
Periodic Reports on the Company's Political Contributions
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
7
Performance-Based Stock Options
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Eli Lilly & Co.
LLY
532457-108
04/18/05
8
Animal Testing
issuer
Yes
For
For
AMIDEX35 Israel
Osem Investments
OSEM
 
04/19/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Osem Investments
OSEM
 
04/19/05
2
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
IDB Development
IDBD
 
04/21/05
1
Approve Payment to Directors
issuer
Yes
Against
For
AMIDEX35 Israel
IDB Development
IDBD
 
04/21/05
2
Approve to Renew Existing D&O Basic and Group Insurances
issuer
Yes
For
For
AMIDEX35 Israel
IDB Development
IDBD
 
04/21/05
3
Approve Purchase of D&O Insurance
issuer
Yes
For
For
AMIDEX35 Israel
IDB Development
IDBD
 
04/21/05
4
Approve Grant to D&O
issuer
Yes
For
For
AMIDEX35 Israel
IDB Development
IDBD
 
04/21/05
5
Approve Grant to D&O
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Wyeth
VRTX
983024-100
04/21/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Wyeth
VRTX
983024-100
04/21/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Wyeth
VRTX
983024-100
04/21/05
3
Approve 2005 Stock Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Wyeth
VRTX
983024-100
04/21/05
4
Reimportation of Prescription Drugs
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Wyeth
VRTX
983024-100
04/21/05
5
Separate Roles of Chairman and CEO
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Wyeth
VRTX
983024-100
04/21/05
6
Disclosure of Political Contributions
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Wyeth
VRTX
983024-100
04/21/05
7
Discontinue Promoting Premarin and Protection of Mares
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
3
Executive Compensation
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
4
Performance-Based Stock Options
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
5
In Vitro Testing
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
6
Political Contributions
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
7
HIV/AIDS-TB-Malaria Pandemics
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Abbott Labratories
ABT
002824-11
04/22/05
8
Separating the Roles of Chairman and CEO
issuer
Yes
For
For
AMIDEX35 Israel
IDB Development
IDBD
 
04/26/05
6
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
3
Stockholder Proposal Concerning Stock Option Awards
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
4
Subjecting Non-Deductible Executive Compensation to Shareholder Vote
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
5
Elimination of Animal-Based Test Methods
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
6
Separating the Roles of Chairman and CEO
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
7
Availability of Company Products to Canadian Wholesalers
issuer
Yes
against
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
8
Use of Shareholder Resources for Political Purposes
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Merck & Co.
MRK
589331-107
04/26/05
9
Report Related to the Global HIV/AIDS-TB-Malaria Pandemics
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Schering-Plough
SGP
806605-101
04/26/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Schering-Plough
SGP
806605-101
04/26/05
2
Ratification of Designation of Independent Registered Public Accounting Firm
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Schering-Plough
SGP
806605-101
04/26/05
3
Shareholder Proposal that Directors be Elected Annually
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Schering-Plough
SGP
806605-101
04/26/05
4
Shareholder Proposal on Animal Testing
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Johnson & Johnson
JNJ
478160-104
04/28/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Johnson & Johnson
JNJ
478160-104
04/28/05
2
Approve Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Johnson & Johnson
JNJ
478160-104
04/28/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-108
05/03/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-109
05/03/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-110
05/03/05
3
Approval of Restated Certificate of Incorporation
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-111
05/03/05
4
Political Contributions
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-112
05/03/05
5
HIV/AIDS-TB-Malaria Pandemics
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-113
05/03/05
6
Animal Testing
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-114
05/03/05
7
Separation of Chairman and CEO positions
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-115
05/03/05
8
Restatement Situations
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-116
05/03/05
9
Restricted Stock
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Bristol-Myers Squibb
BMY
110122-117
05/03/05
10
Director vote Threshhold
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Millennium Pharmaceuticals
MLNM
599902-103
05/05/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Millennium Pharmaceuticals
MLNM
599902-104
05/05/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
05/09/05
1
Approve Option for Insurance Policy
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
05/09/05
2
Approve Grant of Indemnity
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Gilead Sciences
GILD
375558-103
05/10/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Gilead Sciences
GILD
375558-104
05/10/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Gilead Sciences
GILD
375558-105
05/10/05
3
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Gilead Sciences
GILD
375558-106
05/10/05
4
Report Related to the Global HIV/AIDS-TB-Malaria Pandemics
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Cytyc Corp
CYTC
232946-103
05/11/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Cytyc Corp
CYTC
232946-104
05/11/05
2
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Cytyc Corp
CYTC
232946-105
05/11/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Vertex Pharmaceuticals
VRTX
92532F-100
05/11/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Vertex Pharmaceuticals
VRTX
92532F-100
05/11/05
2
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX35 Israel
Clal Insurance
CLIS
 
05/13/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Clal Insurance
CLIS
 
05/13/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Clal Insurance
CLIS
 
05/13/05
3
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Clal Insurance
CLIS
 
05/13/05
4
Approve Purchase of D&O Insurance
issuer
Yes
For
For
AMIDEX35 Israel
Israel Chemicals
CHIM
 
05/16/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Israel Chemicals
CHIM
 
05/16/05
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Israel Chemicals
CHIM
 
05/16/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Israel Discount Bank
DSCT
 
05/16/05
1
Approve Purchase of D&O Insurance
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
05/19/05
1
Approve Agreements Between Company and Government of Israel
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
05/19/05
2
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Medimmune
MEDI
584699-102
05/19/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Medimmune
MEDI
584699-103
05/19/05
2
Approve Ammendment to Stock Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Medimmune
MEDI
584699-104
05/19/05
3
Confirm and Approve Shareholding Rights Plan Agreement
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Medarex
MEDX
583916-101
05/19/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Medarex
MEDX
583916-101
05/19/05
2
Approve 2005 Equity Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Medarex
MEDX
583916-101
05/19/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Mercury Interactive
MERQ
589405-109
05/19/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Mercury Interactive
MERQ
589405-110
05/19/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Valeant Pharmaceuticals
VRTX
91911X-104
05/24/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Chiron Corp
CHIR
170040-109
05/25/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Chiron Corp
CHIR
170040-109
05/25/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-105
05/25/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-106
05/25/05
2
Remuneration Report
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-107
05/25/05
3
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-108
05/25/05
4
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-109
05/25/05
5
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-110
05/25/05
6
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-111
05/25/05
7
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-112
05/25/05
8
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-113
05/25/05
9
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-114
05/25/05
10
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-115
05/25/05
11
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-116
05/25/05
12
Authorize Company to Make Donations to EU Political Organizations
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-117
05/25/05
13
Disapplication of Pre-Emption Rights
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-118
05/25/05
14
Authority for Company to Purchase its Own Shares
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Human Genome
HGSI
444903-108
05/25/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
3
Fix the Number of Directors at Ten
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
4
Confirm and Approve Shareholding Rights Plan Agreement
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
5
Remove Application of Pre-Existing Company Provisions
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
6
Edit Notice of Articles
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
7
Renew and Revise Articles
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
QLT
QLTI
746927-102
05/25/05
8
Amend New Articles
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Valeant Pharmaceuticals
VRTX
91911X-105
05/25/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
3
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
4
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
5
Authorize Directors to Fix the Remuneration of the Auditors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
6
Authorize Directors to Issue Securities
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
7
Disapplication of Pre-Emption Rights
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
8
Company Make Market Purchases of Own Shares
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Elan Corporation
ELN
284131-208
05/26/05
9
Set Re-Issue Price Range for Treasury Shares
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Genzyme Corporation
GENZ
372917-104
05/26/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Genzyme Corporation
GENZ
372917-105
05/26/05
2
Amend Employee Stock Purchase Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Genzyme Corporation
GENZ
372917-106
05/26/05
3
Amend the Equity Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Genzyme Corporation
GENZ
372917-107
05/26/05
4
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Genzyme Corporation
GENZ
372917-108
05/26/05
5
Shareholder Proposal that Directors be Elected Annually
issuer
Yes
Against
For
AMIDEX Cancer Innovations & Healthcare Fund
Human Genome
HGSI
444903-109
05/26/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Electronics For Imaging
EFII
286082-102
06/02/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Biogen Idec
BGEN
09062X-103
06/03/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Biogen Idec
BGEN
09062X-103
06/03/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Biogen Idec
BGEN
09062X-103
06/03/05
3
Approve Omnibus Equity Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Biogen Idec
BGEN
09062X-103
06/03/05
4
Approve Ammendment to Employee Stock Purchase Plan
issuer
Yes
For
For
AMIDEX35 Israel
Bezeq
BEZQ
 
06/08/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-119
06/08/05
15
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-120
06/08/05
16
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Glaxosmithkline PLC
GSK
37733W-121
06/08/05
17
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Protein Design Labs
PDLI
74369L-103
06/08/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Protein Design Labs
PDLI
74369L-103
06/08/05
2
Approve equity incentive plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Protein Design Labs
PDLI
74369L-103
06/08/05
3
Amend Outside Directors Stock Option Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Protein Design Labs
PDLI
74369L-103
06/08/05
4
Amend Certificate of Incorporation
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Protein Design Labs
PDLI
74369L-103
06/08/05
5
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Protein Design Labs
PDLI
74369L-103
06/08/05
6
Approve Adjournments of the Meeting
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abgenix
ABGX
00339B-107
06/13/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abgenix
ABGX
00339B-107
06/13/05
2
Approve Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abgenix
ABGX
00339B-107
06/13/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Abgenix
ABGX
00339B-107
06/13/05
4
Proxies Authorized to Vote
issuer
Yes
Abstain
For
AMIDEX Cancer Innovations & Healthcare Fund
Celgene Corporation
CELG
151020-104
06/15/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Imclone Systems
IMCL
45245W-109
06/15/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Imclone Systems
IMCL
45245W-110
06/15/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Imclone Systems
IMCL
45245W-111
06/15/05
3
Approve Imclone Systems Incorporated 2005 Stock Incentive Plan
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
3
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
4
Approve Payment to Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
5
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
6
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
7
Approve Procedures for Proper Office Holder Performance
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
8
Approve Bonus to Chairman of the Board for 2004
issuer
Yes
Against
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/15/05
9
Approve Purchase of D&O Insurance
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Celgene Corporation
CELG
151020-105
06/16/05
2
Ammend Stock Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Celgene Corporation
CELG
151020-106
06/16/05
3
Ammend Non-Employee Directors' Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Celgene Corporation
CELG
151020-107
06/16/05
4
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Comverse Technology
CMVT
205862-402
06/16/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Comverse Technology
CMVT
205862-402
06/16/05
2
Approve Stock Incentive Compensation Plan
issuer
Yes
For
For
AMIDEX35 Israel
Comverse Technology
CMVT
205862-402
06/16/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Verint Systems
VRNT
92343X-100
06/16/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Verint Systems
VRNT
92343X-100
06/16/05
2
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Cell Therapeutics
CTIC
150934-107
06/17/05
1
Elect Directors
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Cell Therapeutics
CTIC
150934-108
06/17/05
2
Amend the Equity Incentive Plan
issuer
Yes
For
For
AMIDEX Cancer Innovations & Healthcare Fund
Cell Therapeutics
CTIC
150934-109
06/17/05
3
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
2
Re-elect officiating Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
3
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
4
Approve Payment to Directors
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
5
Re-appoint the Auditors and authorize their fees
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
6
Amend provisions of the Article of Association
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
7
Approve Procedures for Proper Office Holder Performance
issuer
Yes
For
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
8
Approve Bonus to Chairman of the Board for 2004
issuer
Yes
Against
For
AMIDEX35 Israel
Bank Leumi
LUMI
 
06/20/05
9
Approve Purchase of D&O Insurance
issuer
Yes
For
For
AMIDEX35 Israel
Africa Israel Investments
AFIL
 
06/21/05
1
Approve Transaction in Accordance with a Subsidiary of the Company
issuer
Yes
For
For
AMIDEX35 Israel
Africa Israel Investments
AFIL
 
06/21/05
2
Approve Purchase of Holding Company
issuer
Yes
For
For
AMIDEX35 Israel
Africa Israel Investments
AFIL
 
06/21/05
3
Approve Paricipation by Holding Company in Investment
issuer
Yes
For
For
AMIDEX35 Israel
Discount Investment
DISI
 
06/21/05
1
Receive and approve the Financial Statements
issuer
Yes
For
For
AMIDEX35 Israel
Discount Investment
DISI
 
06/21/05
2
Elect Directors
issuer
Yes
For
For
AMIDEX35 Israel
Discount Investment
DISI
 
06/21/05
3
Appoint Company's CPA's and Determine their Fee
issuer
Yes
For
For
 
  
 

  

SIGNATURES
 
 
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)   AMIDEX Funds, Inc.           

By (Signature and Title)*  /s/ Cliff Goldstein     

Date           August 23, 2005            
* Print the name and title of each signing officer under his or her signature.